This Phase 3 Trial has Shown Improved Overall Survival - Toxicity Profile has been stable with prolonged exposure to drugs

Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses this phase 3 trial has shown improved overall survival and toxicity profile has been stable with prolonged exposure to ... Author: ASHReport Added: 01/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts